Suppr超能文献

大鼠肠系膜体内对血管紧张素II和[苯丙氨酸4]-血管紧张素II的快速耐受性。

Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo.

作者信息

Tofovic S P, Jackson E K

机构信息

Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pennsylvania, USA.

出版信息

J Pharmacol Exp Ther. 1996 Jan;276(1):13-20.

PMID:8558421
Abstract

The existence of tachyphylaxis to angiotensin II (Ang II) in vivo is not unequivocally established, and the hydroxyl group of the Tyr4 residue of Ang II has been suggested as a determinant of tachyphylaxis. In view of these observations, we conducted a series of experiments to assess and compare the ability of Ang II and [Phe4]-Ang II to induce tachyphylaxis in vivo. All experiments were performed in the autoperfused rat mesenteric vascular bed. The tachyphylaxis to intramesenteric (IMA) infusions of Ang II was minimal, and after 120 min of continuous infusion (33 pmol/min), Ang II retained most of its vasoconstrictor activity (67.7 +/- 6.6% of the initial response). Also most of the agonist activity was retained even when Ang II was administered continuously in a dose-increasing manner (1-33 pmol/min). Continuous IMA infusions of single doses of [Phe4]-Ang II caused an initial full response that rapidly declined, and after 120 min retained only 18.2 +/- 9.2% of the initial response. Single continuous IMA infusion of [Phe4]-Ang II induced greater vasoconstrictor responses compared with vascular responses to the same doses delivered after the infusion of smaller doses. This difference was significant (P < .001, unpaired Student's t test) for all doses (10, 100, 330 and 1000 pmol/min) of [Phe4]-Ang II. In conclusion, although the development of tachyphylaxis to Ang II in vivo is minimal, tachyphylaxis to [Phe4]-Ang II does occur (at least in rat mesenteric vascular bed). Thus, omission of the hydroxyl group in position 4 dramatically increases the tachyphylactic potential, while preserving full agonist activity. These results suggest that the hydroxyl group of Tyr4 may protect the Ang II receptor from changes that induce tachyphylaxis.

摘要

血管紧张素II(Ang II)在体内是否存在快速耐受性尚未明确确定,并且有人提出Ang II的Tyr4残基的羟基是快速耐受性的决定因素。鉴于这些观察结果,我们进行了一系列实验,以评估和比较Ang II和[Phe4]-Ang II在体内诱导快速耐受性的能力。所有实验均在自体灌注的大鼠肠系膜血管床中进行。对肠系膜内(IMA)输注Ang II的快速耐受性最小,在连续输注120分钟(33 pmol/分钟)后,Ang II保留了大部分血管收缩活性(初始反应的67.7±6.6%)。即使以剂量递增的方式(1-33 pmol/分钟)连续给予Ang II,大部分激动剂活性也得以保留。单剂量[Phe4]-Ang II的连续IMA输注引起初始完全反应,但迅速下降,120分钟后仅保留初始反应的18.2±9.2%。与在输注较小剂量后给予相同剂量的血管反应相比,[Phe4]-Ang II的单次连续IMA输注诱导了更大的血管收缩反应。对于所有剂量(10、100、330和1000 pmol/分钟)的[Phe4]-Ang II,这种差异均具有统计学意义(P <.001,未配对学生t检验)。总之,虽然Ang II在体内的快速耐受性发展最小,但[Phe4]-Ang II的快速耐受性确实会发生(至少在大鼠肠系膜血管床中)。因此,第4位羟基的缺失显著增加了快速耐受的可能性,同时保留了完全激动剂活性。这些结果表明,Tyr4的羟基可能保护Ang II受体免受诱导快速耐受性的变化影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验